When shock events impact the medicines supply chain, underlying vulnerabilities can cause it to break instead of bend, resulting in drug shortages. Such shocks can include an increase in demand due to emerging public health concerns.

Manufacturing products locally for more equitable pandemic responses

Investments to create a more resilient medicines supply chain and prepare for future public health emergencies are among key provisions of the mammoth $1.7 trillion, bipartisan government appropriations bill signed in

The World Health Organization (WHO) recently issued a Medical Product Alert after four substandard products were identified in The Gambia, which may be linked to t